WHO ICTRP trial
Effects of subanesthetic dose of esketamine on postoperative cognitive function…
ChiCTR2500104396 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting
Key facts
| Trial ID | ChiCTR2500104396 |
|---|---|
| Public title | Effects of subanesthetic dose of esketamine on postoperative cognitive function and early recovery in elderly patients with hip fracture |
| Scientific title | Effects of subanesthetic dose of esketamine on postoperative cognitive function and early recovery in elderly patients with hip fracture |
| Primary sponsor | People's Hospital of Fuyang City |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Not Recruiting |
| Study type | Interventional study |
| Countries | China |
| Conditions | Postoperative cognitive dysfunction, POCD |
| Interventions | Esketamine group :Esketamine was administered intravenously at a dose of 0.2 mg/kg ;Control group:Intraoperative normal saline infusion |
| Registration date | Jun 17, 2025 |
| Target size | Esketamine group :40;Control group:40 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: